Should AMA 'Support' a Registry to Track Side Effects of GLP-1 Drugs?

(MedPage Today) — CHICAGO — Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse events tied to blockbuster diabetes and weight-loss medications during an open forum at the AMA’s annual…

Source link : https://www.medpagetoday.com/meetingcoverage/ama/115994

Author :

Publish date : 2025-06-10 15:40:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Should AMA ‘Support’ a Registry to Track Side Effects of GLP-1 Drugs?

The AMA Could Have Spoken Louder About Politicization, Board Chair Says

MPs set to vote on decriminalising abortion in England and Wales

Related Posts

Major Medical Groups Pushed Out of Role Supporting CDC’s Vaccine Advisors

‘It’s Gonna Be (Ly)me’: Justin Timberlake Brings Attention, Awareness to Disease

ACOG No Longer Accepting Federal Funding, Citing Policy Disputes

States Sue Trump, Say Targeting of Hospitals Over Gender Care in Minors Is Unlawful

Time Your Meals, Tune Your Metabolism

Novel Eye Drops for Age-Related Blurry Vision Win FDA Approval

Major Medical Groups Pushed Out of Role Supporting CDC’s Vaccine Advisors

‘It’s Gonna Be (Ly)me’: Justin Timberlake Brings Attention, Awareness to Disease

ACOG No Longer Accepting Federal Funding, Citing Policy Disputes

States Sue Trump, Say Targeting of Hospitals Over Gender Care in Minors Is Unlawful

Time Your Meals, Tune Your Metabolism

Novel Eye Drops for Age-Related Blurry Vision Win FDA Approval

Bone Health in Duchenne Muscular Dystrophy

Could we get quantum spookiness even without entanglement?

Categories

Archives